SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a ...
Rejuvenate Bio is a gene therapy startup that seeks to reverse aging. In response to emailed questions, CEO and Co-founder Daniel Oliver talked about how he and his co-founder started the company and ...
Gad Medical Ltd. Receives Regulatory Approval to Start Sales of Ruthless Spine’s RJB Interoperative Angle Measurement Instrument in Israel, Marking Significant Expansion Following NASS Momentum ...
SHARES in RJB Mining, Britain's biggest coal miner, closed nearly 14% higher yesterday as hopes rose again of an imminent bid from US conglomerate Renco. The loss-making coal miner closed 7.5p up at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results